CRB1相关视网膜营养不良的自然病史前瞻性研究
这项单中心前瞻性病例系列研究纳入22例CRB1相关视网膜营养不良患者,基线与2年后进行多项眼科评估。结果显示2年内BCVA和V4e等视线视网膜面积无显著变化,但微视野黄斑敏感度显著下降,提示其可能作为更敏感的功能性临床终点。
要点
- CRB1相关视网膜营养不良以视网膜色素变性为主(19例,86%)。
- 2年随访BCVA与V4e等视线视网膜面积无显著变化。
- 微视野黄斑敏感度显著下降,或为更敏感的进展标志物。
核心结论
- CRB1相关视网膜营养不良患者2年内视力与视野相对稳定,微视野视网膜敏感度显著下降。
- 微视野视网膜敏感度可能作为未来治疗试验的功能性临床终点。
研究设计与样本
- 单中心前瞻性病例系列,纳入22例CRB1相关视网膜营养不良患者。
- 基线与2年后进行眼科评估,包括BCVA、Goldmann动态视野、微视野、全视野ERG、FST及影像学检查。
主要发现
- 基因、临床及电生理诊断:视网膜色素变性19例(86%)、锥杆营养不良2例(9%)、孤立性黄斑营养不良1例(5%)。
- 2年随访全队列BCVA无显著变化(P = .069),V4e等视线视网膜面积无显著变化(P = .616)。
- 微视野黄斑敏感度在2年随访显著下降(P < .001)。
- 全视野ERG不可记录的患者中FST反应可测得,FST反应平均随访期间保持稳定。
关键数值与推荐
- BCVA变化P = .069(无统计学显著性)。
- V4e等视线视网膜面积变化P = .616(无统计学显著性)。
- 微视野黄斑敏感度下降P < .001(有统计学显著性)。
临床怎么用
- 对CRB1相关视网膜营养不良患者,微视野可检测2年内视网膜敏感度下降,或优于BCVA和视野。
- 微视野视网膜敏感度可作为未来临床试验的功能性终点候选指标。
局限性
- 单中心前瞻性病例系列,样本量22例。
- 随访时间仅2年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the natural disease course of retinal dystrophies associated with crumbs cell polarity complex component 1 (CRB1) and identify clinical end points for future clinical trials. DESIGN: Single-center, prospective case series. METHODS: An investigator-initiated nationwide collaborative study that included 22 patients with CRB1-associated retinal dystrophies. Patients underwent ophthalmic assessment at baseline and 2 years after baseline. Clinical examination included best-corrected visual acuity (BCVA) using Early Treatment Diabetic Retinopathy Study charts, Goldmann kinetic perimetry (V4e isopter seeing retinal areas), microperimetry, full-field electroretinography, full-field stimulus threshold (FST), fundus photography, spectral-domain optical coherence tomography, and fundus autofluorescence imaging. RESULTS: Based on genetic, clinical, and electrophysiological data, patients were diagnosed with retinitis pigmentosa (19 [86%]), cone-rod dystrophy (2 [9%]), or isolated macular dystrophy (1 [5%]). Analysis of the entire cohort at 2 years showed no significant changes in BCVA (P = .069) or V4e isopter seeing retinal areas (P = .616), although signs of clinical progression were present in individual patients. Macular sensitivity measured on microperimetry revealed a significant reduction at the 2-year follow-up (P < .001). FST responses were measurable in patients with nonrecordable electroretinograms. On average, FST responses remained stable during follow-up. CONCLUSION: In CRB1-associated retinal dystrophies, visual acuity and visual field measures remain relatively stable over the course of 2 years. Microperimetry showed a significant decrease in retinal sensitivity during follow-up and may be a more sensitive progression marker. Retinal sensitivity on microperimetry may serve as a functional clinical end point in future human treatment trials for CRB1-associated retinal dystrophies.
引用
- Nguyen XT, Talib M, van Schooneveld MJ, et al. CRB1-Associated Retinal Dystrophies: A Prospective Natural History Study in Anticipation of Future Clinical Trials. Am J Ophthalmol. 2021. PMID: 34320374. doi:10.1016/j.ajo.2021.07.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。